No Data
No Data
J.P. Morgan Reaffirms Their Buy Rating on Smith & Nephew (SN)
Barclays Sticks to Their Hold Rating for Smith & Nephew (SN)
Smith & Nephew CEO Turns Down Calls for Spinoff of Orthopedics Business
Top Gap Ups and Downs on Tuesday: LI, PHG, MSTR and More
Smith & Nephew Up Over 7%, on Pace for Largest Percent Increase Since November 2020 -- Data Talk
Smith & Nephew Reports Strong 2024 Financial Results Amid Transformation